RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 1 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $196 | -40.1% | 65,275 | -50.8% | 0.00% | – |
| Q2 2023 | $327 | -53.8% | 132,772 | -57.6% | 0.00% | -100.0% |
| Q1 2023 | $708 | -6.8% | 313,175 | +43.8% | 0.00% | 0.0% |
| Q4 2022 | $760 | -99.8% | 217,810 | +1412.6% | 0.00% | – |
| Q4 2021 | $324,000 | -20.2% | 14,400 | -7.1% | 0.00% | -100.0% |
| Q3 2021 | $406,000 | – | 15,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 853,206 | $30,041,000 | 3.26% |
| COMMODORE CAPITAL LP | 161,565 | $5,689,000 | 2.27% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $7,042,000 | 1.98% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 451,412 | $15,894,000 | 1.30% |
| Avoro Capital Advisors LLC | 1,525,000 | $53,695,000 | 0.93% |
| RTW INVESTMENTS, LP | 1,530,717 | $53,897,000 | 0.84% |
| Pegasus Asset Management, Inc. | 26,958 | $949,000 | 0.48% |
| COWEN AND COMPANY, LLC | 166,942 | $5,878,000 | 0.40% |
| Ikarian Capital, LLC | 290,207 | $10,218,000 | 0.34% |
| Spotlight Asset Group, Inc. | 24,565 | $865,000 | 0.32% |